| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9844 | 
      | Human Intestinal Absorption | HIA+ | 0.9852 | 
      | Caco-2 Permeability | Caco2+ | 0.8203 | 
      | P-glycoprotein Substrate | Substrate | 0.8092 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8563 | 
                                                     | Inhibitor | 0.8570 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.7087 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4659 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7438 | 
      | CYP450 2D6 Substrate | Substrate | 0.8618 | 
      | CYP450 3A4 Substrate | Substrate | 0.6468 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9106 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9319 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9115 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7333 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9537 | 
                                                                    | Inhibitor | 0.7813 | 
      | AMES Toxicity | Non AMES toxic | 0.8490 | 
      | Carcinogens | Non-carcinogens | 0.9292 | 
      | Fish Toxicity | High FHMT | 0.6477 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.6541 | 
      | Honey Bee Toxicity | Low HBT | 0.7401 | 
      | Biodegradation | Not ready biodegradable | 0.9829 | 
      | Acute Oral Toxicity | III | 0.7696 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7124 |